Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'carmustine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 180 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dillman, RO; Shea, WM; Tai, DF; Mahdavi, K; Barth, NM; Kharkar, BR; Poor, MM; Church, CK; DePriest, C
      Interferon-alpha 2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma

      NEURO-ONCOLOGY
    2. Demir, A; Ozutemiz, O; Yildiz, C; Yuce, G; Tekesin, O; Ilter, T
      The effect of trimetazidine on intrahepatic cholestasis caused by carmustine in rats

      HEPATOLOGY RESEARCH
    3. McGaughey, DS; Nikcevich, DA; Long, GD; Vredenburgh, JJ; Rizzieri, D; Smith, CA; Broadwater, G; Loftis, FS; McDonald, C; Morris, AK; Folz, RJ; Chao, NJ
      Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome inbreast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    4. Stuart, MJ; Chao, NS; Horning, SJ; Wong, RM; Negrin, RS; Johnston, LJ; Shizuru, JA; Long, GD; Blume, KG; Stockerl-Goldstein, KE; Goldstein, S
      Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    5. Wheeler, C; Khurshid, A; Ibrahim, J; Elias, A; Mauch, P; Ault, K; Antin, J
      Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV)

      LEUKEMIA & LYMPHOMA
    6. Mc Clay, EF; Mc Clay, MET; Monroe, L; Jones, JA; Winski, PJ
      A phase II study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

      MELANOMA RESEARCH
    7. Sileni, VC; Nortilli, R; Aversa, SML; Paccagnella, A; Medici, M; Corti, L; Favaretto, AG; Cetto, GL; Monfardini, S
      Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

      MELANOMA RESEARCH
    8. Nachbaur, D; Oberaigner, W; Fritsch, E; Nussbaumer, W; Gastl, G
      Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience

      EUROPEAN JOURNAL OF HAEMATOLOGY
    9. Brandes, AA; Palmisano, V; Pasetto, LM; Basso, U; Monfardini, S
      High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults

      CANCER INVESTIGATION
    10. Akpek, G; Ambinder, RF; Piantadosi, S; Abrams, RA; Brodsky, RA; Vogelsang, GB; Zahurak, ML; Fuller, D; Miller, CB; Noga, SJ; Fuchs, E; Flinn, IW; O'Donnell, P; Seifter, EJ; Mann, RB; Jones, RJ
      Long-term results of blood and marrow transplantation for Hodgkin's lymphoma

      JOURNAL OF CLINICAL ONCOLOGY
    11. Tanaka, M; Shibui, S; Nomura, K; Nakanishi, Y
      Radiotherapy combined with nimustine hydrochloride and etoposide for malignant gliomas: Results of a pilot study

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    12. Prados, MD; Wara, WM; Sneed, PK; McDermott, M; Chang, SM; Rabbitt, J; Page, M; Malec, M; Davis, RL; Gutin, PH; Lamborn, K; Wilson, CB; Phillips, TL; Larson, DA
      Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    13. Brem, H; Gabikian, P
      Biodegradable polymer implants to treat brain tumors

      JOURNAL OF CONTROLLED RELEASE
    14. Boiardi, A; Silvani, A; Ciusani, E; Watson, A; Margison, G; Berger, E; Lucas, C; Giroux, B
      Fotemustine combined with procarbazine in recurrent malignant gliomas: A phase I study with evaluation of lymphocyte O-6-alkylguanine-DNA alkyltransferase activity

      JOURNAL OF NEURO-ONCOLOGY
    15. Buckner, JC; Schomberg, PJ; McGinnis, WL; Cascino, TL; Scheithauer, BW; O'Fallon, JR; Morton, RF; Kuross, SA; Mailliard, JA; Hatfield, AK; Cole, JT; Steen, PD; Bernath, AM
      A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosedhigh-grade glioma

      CANCER
    16. Dillman, RO; Soori, G; Wiemann, MC; Schulof, R; Dobbs, TW; Ruben, RH; DePriest, CB; Church, C
      Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: Final results of Cancer Biotherapy Research Group94-11

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    17. Cao, TM; Negrin, RS; Stockerl-Goldstein, KE; Johnston, LJ; Shizuru, JA; Taylor, TL; Rizk, NW; Wong, RM; Blume, KG; Hu, WW
      Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    18. Flaherty, LE
      Rationale for intergroup trial E-3695 comparing concurrent biochemotherapyth cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    19. Heimberger, AB; Archer, GE; McLendon, RE; Hulette, C; Friedman, AH; Friedman, HS; Bigner, DD; Sampson, JH
      Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats

      CLINICAL CANCER RESEARCH
    20. Frenay, M; Lebrun, C; Lonjon, M; Bondiau, PY; Chatel, M
      Up-front chemotherapy with fotemustine (F)/cisplatin (CDDP)/etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas

      EUROPEAN JOURNAL OF CANCER
    21. Neben, K; Hohaus, S; Goldschmidt, H; Egerer, G; Voso, MT; Ho, AD; Haas, R
      High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors

      ANNALS OF HEMATOLOGY
    22. La Barbera, EO; Chiusolo, P; Laurenti, L; Menichella, G; Di Febo, AL; Piccirillo, N; Sora, F; Marra, R; Teofili, L; Leone, G; Sica, S
      MiCMA: An alternative treatment for refractory or recurrent Hodgkin's disease

      ANNALS OF ONCOLOGY
    23. Armitage, JO
      Management of relapsed Hodgkin's disease patients with high-dose chemotherapy and marrow stem-cell transplantation

      ANNALS OF ONCOLOGY
    24. Shamash, J; Lee, SM; Radford, JA; Rohatiner, AZS; Chang, J; Morgenstern, GR; Scarffe, JH; Deakin, DP; Lister, TA
      Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study

      ANNALS OF ONCOLOGY
    25. Emerich, DF; Dean, RL; Marsh, J; Pink, M; Lafreniere, D; Snodgrass, P; Bartus, RT
      Intravenous Cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in bats with metastatic tumors in the brain

      PHARMACEUTICAL RESEARCH
    26. Hung, CF
      Effects of carmustine and lomustine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adducts in rat glial tumor cells

      NEUROCHEMICAL RESEARCH
    27. Kokkinakis, DM; Moschel, RC; Pegg, AE; Schold, SC
      Potentiation of BCNU antitumor efficacy by 9-substituted O-6-benzylguanines. Effect of metabolism

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    28. Bogart, JA; Zamkoff, K; Chung, CT
      Aggressive radiotherapy adjuvant to peripheral blood stem cell transplant for relapsed Hodgkin's disease

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    29. Papadakis, V; Dunkel, IJ; Cramer, LD; Kramer, E; Papadopoulos, E; Goldman, S; Packer, RJ; Willoughby, M; Baker, D; Garvin, J; Strandjord, S; Coccia, P; Kaplan, AM; Klemperer, M; Finlay, JL
      High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors

      BONE MARROW TRANSPLANTATION
    30. Alessandrino, EP; Bernasconi, P; Colombo, A; Caldera, D; Martinelli, G; Vitulo, P; Malcovati, L; Nascimbene, C; Varettoni, M; Volpini, E; Klersy, C; Bernasconi, C
      Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies

      BONE MARROW TRANSPLANTATION
    31. Bodell, WJ
      Measurement of sister chromatid exchange induction in intracerebral brain tumors as a method for evaluation of therapeutic drug combinations

      ANTICANCER RESEARCH
    32. Wakabayashi, T; Hatano, N; Kajita, Y; Yoshida, T; Mizuno, M; Taniguchi, K; Ohno, T; Nagasaka, T; Yoshida, J
      Initial and maintenance combination treatment with interferon-beta, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma

      JOURNAL OF NEURO-ONCOLOGY
    33. Fels, C; Schafer, C; Huppe, B; Bahn, H; Heidecke, V; Kramm, CM; Lautenschlager, C; Rainov, NG
      Bcl-2 expression in higher-grade human glioma: A clinical and experimentalstudy

      JOURNAL OF NEURO-ONCOLOGY
    34. Thomson, KF; Sheehan-Dare, RA; Wilkinson, SM
      Allergic contact dermatitis from topical carmustine

      CONTACT DERMATITIS
    35. Engelhard, HH
      The role of interstitial BCNU chemotherapy in the treatment of malignant glioma

      SURGICAL NEUROLOGY
    36. Engelhard, HH
      Tumor bed cyst formation after BCNU wafer implantation: Report of two cases

      SURGICAL NEUROLOGY
    37. Frenay, M; Lebrun, C; Lonjon, M; Marcy, PY; Paquis, P
      Fotemustine(F)/cisplatine(CDDP)/etoposide combination with brain irradiation in the treatment of non removable high grade gliomas (HGG)

      REVUE NEUROLOGIQUE
    38. Ma, DQ; Rajewski, RA; Vander Velde, D; Stella, VJ
      Comparative effects of (SBE)(7m)-beta-CD and HP-beta-CD on the stability of two anti-neoplastic agents, melphalan and carmustine

      JOURNAL OF PHARMACEUTICAL SCIENCES
    39. Becker, K; Gromer, S; Schirmer, RH; Muller, S
      Thioredoxin reductase as a pathophysiological factor and drug target

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    40. Norman, SA; Rhodes, SN; Treasurywala, S; Hoelzinger, DB; Shapiro, JR; Scheck, AC
      Identification of transforming growth factor-beta 1-binding protein overexpression in carmustine-resistant glioma cells by mRNA differential display

      CANCER
    41. Feun, LG; Savaraj, M; Hurley, J; Marini, A; Lai, SH
      A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in thetreatment of patients with advanced malignant melanoma

      CANCER
    42. Keilholz, U; Suciu, S; Eggermont, AMM
      What can we learn from phase II adjuvant trials in melanoma?

      BRITISH JOURNAL OF CANCER
    43. Middleton, MR; Lorigan, P; Owen, J; Ashcroft, L; Lee, SM; Harper, P; Thatcher, N
      A randomized phase III study comparing decarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma

      BRITISH JOURNAL OF CANCER
    44. Propper, DJ; Braybrooke, JP; Levitt, NC; O'Byrne, KO; Christodoulos, K; Han, C; Talbot, DC; Ganesan, TS; Harris, AL
      Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine

      BRITISH JOURNAL OF CANCER
    45. Mundt, AJ; Connell, PP; Mansur, DB
      What is the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy and adjuvant radiation therapy?

      RADIATION ONCOLOGY INVESTIGATIONS
    46. Tsang, RW; Gospodarowicz, MK; Sutcliffe, SB; Crump, M; Keating, A
      Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease

      EUROPEAN JOURNAL OF CANCER
    47. Girgin, F; Tuzun, S; Demir, A; Kuralay, F; Ozutemiz, O; Tanyalcin, T
      Cytoprotective effects of trimetazidine in carmustine cholestasis

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    48. Brice, P; Divine, M; Simon, D; Coiffier, B; Leblond, V; Simon, M; Voilat, L; Devidas, A; Morschhauser, F; Rohrlich, P; Andre, M; Lepage, E; Ferme, C
      Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD)

      ANNALS OF ONCOLOGY
    49. Chapman, PB; Einhorn, LH; Meyers, ML; Saxman, S; Destro, AN; Panageas, KS; Begg, CB; Agarwala, SS; Schuchter, LM; Ernstoff, MS; Houghton, AN; Kirkwood, JM
      Phase III multicenter randomized trial of the dartmouth regimen versus dacarbazine in patients with metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    50. Rosenberg, SA; Yang, JC; Schwartzentruber, DJ; Hwu, P; Marincola, FM; Topalian, SL; Seipp, CA; Einhorn, JH; White, DE; Steinberg, SM
      Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b

      JOURNAL OF CLINICAL ONCOLOGY
    51. Andre, M; Henry-Amar, M; Pico, JL; Brice, P; Blaise, D; Kuentz, M; Coiffier, B; Colombat, P; Cahn, JY; Attal, M; Fleury, J; Milpied, N; Nedellec, G; Biron, P; Tilly, H; Jouet, JP; Gisselbrecht, C
      Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: A case-control study

      JOURNAL OF CLINICAL ONCOLOGY
    52. Domb, AJ; Israel, ZH; Elmalak, O; Teomim, D; Bentolila, A
      Preparation and characterization of carmustine loaded polyanhydride wafersfor treating brain tumors

      PHARMACEUTICAL RESEARCH
    53. Beauchesne, P; Soler, C; Rusch, P; Fotso, MJ; Duthel, R; Schmitt, T; Brunon, J
      Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    54. Johnson, DW; Cagnoni, PJ; Schossau, TM; Stemmer, SM; Grayeb, DEM; Baron, AE; Shpall, EJ; Bearman, SI; McDermitt, J; Jones, RB
      Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support

      BONE MARROW TRANSPLANTATION
    55. Moskowitz, CH; Nimer, SD; Glassman, JR; Portlock, CS; Yahalom, J; Straus, DJ; O'Brien, JP; Elkin, N; Bertino, JR; Zelenetz, AD
      The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma

      BONE MARROW TRANSPLANTATION
    56. Grovas, AC; Boyett, JM; Lindsley, K; Rosenblum, M; Yates, AJ; Finlay, JL
      Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: Report from the Children's Cancer Group

      MEDICAL AND PEDIATRIC ONCOLOGY
    57. Brem, H; Lawson, HC
      The development of new brain tumor therapy utilizing the local and sustained delivery of chemotherapeutic agents from biodegradable polymers

      CANCER
    58. Kashani-Sabet, M; Sagebiel, RW; Collins, HE; Glassberg, AB; Allen, RE; Leong, SPL; Small, EJ
      Outpatient combination chemoimmunotherapy for patients with metastatic melanoma - Results of a phase I/II trial

      CANCER
    59. Agarwala, SS; Ferri, W; Gooding, W; Kirkwood, JM
      A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma

      CANCER
    60. Rodriguez, J; Rodriguez, MA; Fayad, L; McLaughlin, P; Swan, F; Sarris, A; Romaguera, J; Andersson, B; Cabanillas, F; Hagemeister, FB
      ASHAP: A regimen for cytoreduction of refractory or recurrent Hodgkin's disease

      BLOOD
    61. Serody, JS; Cook, DN; Kirby, SL; Reap, E; Shea, TC; Frelinger, JA
      Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 alpha are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier

      BLOOD
    62. NATHAN FE; MASTRANGELO MJ
      SYSTEMIC THERAPY IN MELANOMA

      Seminars in surgical oncology
    63. WILCZYNSKI SW; ERASMUS JJ; PETROS WP; VREDENBURGH JJ; FOLZ RJ
      DELAYED PULMONARY TOXICITY SYNDROME FOLLOWING HIGH-DOSE CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION FOR BREAST-CANCER

      American journal of respiratory and critical care medicine
    64. RICHARD MA; GROB JJ; ZARROUR H; BASSERES N; BIZZARI JP; GERARD B; BONERANDI JJ
      COMBINED TREATMENT WITH DACARBAZINE, CISPLATIN, FOTEMUSTINE AND TAMOXIFEN IN METASTATIC MALIGNANT-MELANOMA

      Melanoma research
    65. Semb, KA; Aamdal, S; Bohmann, T; Lucas, C; Gerard, B
      Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma

      MELANOMA RESEARCH
    66. GUNDERSEN S; LOTE K; WATNE K
      A RETROSPECTIVE STUDY OF THE VALUE OF CHEMOTHERAPY AS ADJUVANT THERAPY TO SURGERY AND RADIOTHERAPY IN GRADE-3 AND GRADE-4 GLIOMAS

      European journal of cancer
    67. RUSTHOVEN JJ
      THE EVIDENCE FOR TAMOXIFEN AND CHEMOTHERAPY AS TREATMENT FOR METASTATIC MELANOMA

      European journal of cancer
    68. JOSTING A; KATAY I; RUEFFER U; WINTER S; TESCH H; ENGERT A; DIEHL V; WICKRAMANAYAKE PD
      FAVORABLE OUTCOME OF PATIENTS WITH RELAPSED OR REFRACTORY HODGKINS-DISEASE TREATED WITH HIGH-DOSE CHEMOTHERAPY AND STEM-CELL RESCUE AT THE TIME OF MAXIMAL RESPONSE TO CONVENTIONAL SALVAGE THERAPY (DEXA-BEAM)

      Annals of oncology
    69. Hoppe, RT
      Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease

      ANNALS OF ONCOLOGY
    70. MCCLAY EF; BERD D; MASTRANGELO MJ
      THE DARTMOUTH REGIMEN - GONE OR GOING STRONG

      Cancer investigation
    71. TAYLOR BV; BUCKNER JC; CASCINO TL; OFALLON JR; SCHAEFER PL; DINAPOLI RP; SCHOMBERG P
      EFFECTS OF RADIATION AND CHEMOTHERAPY ON COGNITIVE FUNCTION IN PATIENTS WITH HIGH-GRADE GLIOMA

      Journal of clinical oncology
    72. FALKSON CI; IBRAHIM J; KIRKWOOD JM; COATES AS; ATKINS MB; BLUM RH
      PHASE-III TRIAL OF DACARBAZINE VERSUS DACARBAZINE WITH INTERFERON-ALPHA-2B VERSUS DACARBAZINE WITH TAMOXIFEN VERSUS DACARBAZINE WITH INTERFERON-ALPHA-2B AND TAMOXIFEN IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    73. Naomoto, Y; Perdomo, JA; Kamikawa, Y; Haisa, M; Yamatsuji, T; Kenzo, A; Taguchi, K; Hara, K; Tanaka, N
      Primary malignant melanoma of the esophagus: Report of a case successfullytreated with pre- and post-operative adjuvant hormone-chemotherapy

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    74. CHAO MWT; WIRTH A; RYAN G; MCMANUS M; LIEW KH
      RADIATION MYELOPATHY FOLLOWING TRANSPLANTATION AND RADIOTHERAPY FOR NON-HODGKINS-LYMPHOMA

      International journal of radiation oncology, biology, physics
    75. SCOTT CB; SCARANTINO C; URTASUN R; MOVSAS B; JONES CU; SIMPSON JR; FISCHBACH AJ; CURRAN WJ
      VALIDATION AND PREDICTIVE POWER OF RADIATION-THERAPY ONCOLOGY GROUP (RTOG) RECURSIVE PARTITIONING ANALYSIS CLASSES FOR MALIGNANT GLIOMA PATIENTS - A REPORT USING RTOG-90-06

      International journal of radiation oncology, biology, physics
    76. Rajkumar, SV; Buckner, JC; Schomberg, PJ; Reid, JM; Bagniewski, PJ; Ames, MM; Cascino, TL; Marks, RS
      Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    77. ARRANZ R; TOMAS JF; GILFERNANDEZ JJ; MARTINEZCHAMORRO C; GRANADOS E; ALEGRE A; FIGUERA A; VAZQUEZ L; CAMARA R; FERNANDEZRANADA JM
      AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR POOR PROGNOSTIC HODGKINS-DISEASE (HD) - COMPARATIVE RESULTS WITH 2 CBV REGIMENS AND IMPORTANCE OF DISEASE STATUS AT TRANSPLANT

      Bone marrow transplantation
    78. LAPORT GF; GRAD G; GRINBLATT DL; BITRAN JD; WILLIAMS SF
      HIGH-DOSE CHEMOTHERAPY CONSOLIDATION WITH AUTOLOGOUS STEM-CELL RESCUEIN METASTATIC BREAST-CANCER - A 10-YEAR EXPERIENCE

      Bone marrow transplantation
    79. KROGER N; HOFFKNECHT M; HANEL M; KRUGER W; ZELLER W; STOCKSCHLADER M; DEWIT M; WEH HJ; KABISCH H; ERTTMANN R; ZANDER AR
      BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AS HIGH-DOSE CONDITIONING THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMA AND PRIOR DOSE-LIMITING RADIATION-THERAPY

      Bone marrow transplantation
    80. Lang, O; Liebermeister, E; Liesegang, J; Sautter-Bihl, ML
      Radiotherapy of glioblastoma multiforme - Feasibility of increased fraction size and shortened overall treatment

      STRAHLENTHERAPIE UND ONKOLOGIE
    81. HSU E; KEENE D; VENTUREYRA E; MATZINGER MA; JIMENEZ C; WANG HS; GRIMARD L
      BONE-MARROW METASTASIS IN ASTROCYTIC GLIOMATA

      Journal of neuro-oncology
    82. EWEND MG; SAMPATH P; WILLIAMS JA; TYLER BM; BREM H
      LOCAL-DELIVERY OF CHEMOTHERAPY PROLONGS SURVIVAL IN EXPERIMENTAL BRAIN METASTASES FROM BREAST-CARCINOMA

      Neurosurgery
    83. KONG QZ; KLEINSCHMIDTDEMASTERS BK; LILLEHEI KO
      INTRALESIONALLY IMPLANTED CISPLATIN PLUS SYSTEMIC CARMUSTINE FOR THE TREATMENT OF BRAIN-TUMOR IN RATS

      Journal of surgical oncology
    84. STARK JJ; DILLMAN RO; SCHULOF R; WIEMANN MC; BARTH NM; HONEYCUTT PJ; SOORI G
      INTERFERON-ALPHA AND CHEMOHORMONAL THERAPY FOR PATIENTS WITH ADVANCEDMELANOMA - FINAL RESULTS OF A PHASE I-II STUDY OF THE CANCER-BIOTHERAPY-RESEARCH-GROUP AND THE MID-ATLANTIC-ONCOLOGY-PROGRAM

      Cancer
    85. SALLOUM E; JILLELLA AP; NADKARNI R; SEROPIAN S; HU GL; DANDREA E; ZELTERMAN D; COOPER DL
      ASSESSMENT OF PULMONARY AND CARDIAC-FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY WITH BEAM AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION

      Cancer
    86. BRANDES AA; RIGON A; ZAMPIERI P; ERMANI M; CAROLLO C; ALTAVILLA G; TURAZZI S; CHIERICHETTI F; FIORENTINO MV
      CARBOPLATIN AND TENIPOSIDE CONCURRENT WITH RADIOTHERAPY IN PATIENTS WITH GLIOBLASTOMA-MULTIFORME - A PHASE-II STUDY

      Cancer
    87. SEHN LH; ANTIN JH; SHULMAN LN; MAUCH P; ELIAS A; KADIN ME; WHEELER C
      PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE MEDIASTINUM - OUTCOME FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC-CELL TRANSPLANTATION

      Blood
    88. WU HM; LEE AG; LEHANE DE; CHI TL; LEWIS RA
      OCULAR AND ORBITAL COMPLICATIONS OF INTRAARTERIAL CISPLATIN - A CASE-REPORT

      Journal of neuro-ophthalmology
    89. ANNALORO C; DELILIERS GL; POZZOLI E; DELLAVOLPE A; ORIANI A; IBATICI A; SOLIGO D; BERTOLLI V; TAGLIAFERRI E
      AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED HODGKINS-DISEASE

      Leukemia & lymphoma
    90. WHITE A; KIBITEL J; GARCIA Y; BELANICH M; YAROSH D; WIDEROFF J; LEVIN L; HELD D; FUCHS A; CITRON M
      O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE IN NORMAL COLON TISSUE AND COLON-CANCER

      Oncology research
    91. EGYHAZI S; EDGREN MR; HANSSON J; KROCKEL D; MANNERVIK B; RINGBORG U
      ROLE OF O-6-METHYLGUANINE-DNA METHYLTRANSFERASE, GLUTATHIONE TRANSFERASE M3-3 AND GLUTATHIONE IN RESISTANCE TO CARMUSTINE IN A HUMAN NONSMALL CELL LUNG-CANCER CELL-LINE

      European journal of cancer
    92. PRINCE HM; WIRTH A; WOLF M
      HODGKINS-DISEASE FAILURES - INCORPORATING RADIOTHERAPY AND HIGH-DOSE TREATMENT

      Journal of clinical oncology
    93. BOLWELL BJ; KALAYCIO M; GOORMASTIC M; DANNLEY R; ANDRESEN SW; LICHTIN A; OVERMOYER B; POHLMAN B
      PROGRESSIVE DISEASE AFTER ABMT FOR HODGKINS-DISEASE

      Bone marrow transplantation
    94. SUREDA A; MATAIX R; HERNANDEZNAVARRO F; JARQUE I; LAHUERTA JJ; TOMAS JF; BRUNET S; CABALLERO D; CONDE E; LEON A; FERNANDEZ MN; LOPEZ A; MALDONADO J; BENGOECHEA E; CALLIS M; CARRERA D; GARCIACONDE J; GARCIALARANA J; MORALEDA JM; MOREY M; RIFON J; SIERRA J; TORRES A; DOMINGOALBOS A
      AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSIS HODGKINS-DISEASE IN FIRST COMPLETE REMISSION - A RETROSPECTIVE STUDY FROM THE SPANISH GEL-TAMO COOPERATIVE GROUP

      Bone marrow transplantation
    95. TSAI T; GOODMAN S; SAEZ R; SCHILLER G; ADKINS D; CALLANDER N; WOLFF S; FREYTES CO
      ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION

      Bone marrow transplantation
    96. BRICE P; BOUABDALLAH R; MOREAU P; DIVINE M; ANDRE M; AOUDJANE M; FLEURY J; ANGLARET B; BARUCHEL A; SENSEBE L; COLOMBAT P
      PROGNOSTIC FACTORS FOR SURVIVAL AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSING HODGKINS-DISEASE - ANALYSIS OF 280 PATIENTS FROM THE FRENCH REGISTRY

      Bone marrow transplantation
    97. DEMAGALHAESSILVERMAN M; LISTER J; RYBKA W; WILSON J; BALL E
      BUSULFAN AND CYCLOPHOSPHAMIDE (BU CY2) AS PREPARATIVE REGIMEN FOR PATIENTS WITH LYMPHOMA/

      Bone marrow transplantation
    98. WOO MH; IPPOLITI C; BRUTON J; MEHRA R; CHAMPLIN R; PRZEPIORKA D
      HEADACHE, CIRCUMORAL PARESTHESIA, AND FACIAL FLUSHING ASSOCIATED WITHHIGH-DOSE CARMUSTINE INFUSION

      Bone marrow transplantation
    99. AHMED T; LAKE DE; BEER M; FELDMAN EJ; PRETI RA; SEITER K; HELSON L; MITTELMAN A; KANCHERLA R; ASCENSAO J; AKHTAR T; COOK P; GOLDBERG R; COLEMAN M
      SINGLE AND DOUBLE AUTOTRANSPLANTS FOR RELAPSING REFRACTORY HODGKINS-DISEASE - RESULTS OF 2 CONSECUTIVE TRIALS/

      Bone marrow transplantation
    100. GRYN J; JOHNSON E; GOLDMAN N; DEVEREUX L; GRANA G; HAGEBOUTROS A; FERNANDEZ E; CONSTANTINOU C; HARRER W; VINER E; GOLDBERG J
      THE TREATMENT OF RELAPSED OR REFRACTORY INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY CYCLOSPORINE AND INTERFERON

      Bone marrow transplantation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 18:01:54